C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2562674
The present invention provides methods of using RNAi in a high throughput screening for the identification and validation of drug targets in a plysiological, disease-relevant context.
La présente invention concerne des procédés pour utiliser une interférence ARN dans le cadre d'un criblage à haut débit permettant d'identifier et de valider des médicaments cibles dans un contexte physiologique lié à une pathologie.
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
LandOfFree
Rnai-based target identification and validation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rnai-based target identification and validation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rnai-based target identification and validation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1752490